Kaushik Sengupta

Dr. Kaushik Sengupta


Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 December 2013 in PLOS ONE
Verified
Journal Article
Open access
PDF file
ABAvinanda Banerjee
Avinanda Banerjee
VRVikram Rathee
Vikram Rathee
RKRema Krishnaswamy
Rema Krishnaswamy
PBPritha Bhattacharjee
Pritha Bhattacharjee
PRPulak Ray
Pulak Ray
KSKaushik Sengupta
Kaushik Sengupta
Lamins are intermediate filament proteins of type V constituting a nuclear lamina or filamentous meshwork which lines the nucleoplasmic side of the inner nuclear membrane. This protein mesh provides a supporting scaffold for the nuclear envelope and tethers interphase chromosome to the nuclear periphery. Mutations of mainly A-type lamins are found to be causative for at least 11 human diseases collectively termed as laminopathies majority of which are characterised by aberrant nuclei with altered structural rigidity, deformability and poor mechanotransduction behaviour. But the investigation of viscoelastic behavior of lamin A continues to elude the field. In order to address this problem, we hereby present the very first report on viscoelastic properties of wild type human lamin A and some of its mutants linked with Dilated cardiomyopathy (DCM) using quantitative rheological measurements. We observed a dramatic strain-softening effect on lamin A network as an outcome of the strain amplitude sweep measurements which could arise from the large compliance of the quasi-cross-links in the network or that of the lamin A rods. In addition, the drastic stiffening of the differential elastic moduli on superposition of rotational and oscillatory shear stress reflect the increase in the stiffness of the laterally associated lamin A rods. These findings present a preliminary insight into distinct biomechanical properties of wild type lamin A protein and its mutants which in turn revealed interesting differences.

5 June 2013 in Biochemistry
Verified
Journal Article
Closed access
PBPritha Bhattacharjee
Pritha Bhattacharjee
ABAvinanda Banerjee
Avinanda Banerjee
ABAmrita Banerjee
Amrita Banerjee
DDDipak Dasgupta
Dipak Dasgupta
KSKaushik Sengupta
Kaushik Sengupta

7 January 2022 in PLOS ONE
Verified
Journal Article
Open access
PDF file
DSDuhita Sengupta
Duhita Sengupta
SASk Nishan Ali
Sk Nishan Ali
ABAditya Bhattacharya
Aditya Bhattacharya
JMJoy Mustafi
Joy Mustafi
AMAsima Mukhopadhyay
Asima Mukhopadhyay
KSKaushik Sengupta
Kaushik Sengupta
Nuclear morphological features are potent determining factors for clinical diagnostic approaches adopted by pathologists to analyze the malignant potential of cancer cells. Considering the structural alteration of the nucleus in cancer cells, various groups have developed machine learning techniques based on variation in nuclear morphometric information like nuclear shape, size, nucleus-cytoplasm ratio and various non-parametric methods like deep learning have also been tested for analyzing immunohistochemistry images of tissue samples for diagnosing various cancers. We aim to correlate the morphometric features of the nucleus along with the distribution of nuclear lamin proteins with classical machine learning to differentiate between normal and ovarian cancer tissues. It has already been elucidated that in ovarian cancer, the extent of alteration in nuclear shape and morphology can modulate genetic changes and thus can be utilized to predict the outcome of low to a high form of serous carcinoma. In this work, we have performed exhaustive imaging of ovarian cancer versus normal tissue and developed a dual pipeline architecture that combines the matrices of morphometric parameters with deep learning techniques of auto feature extraction from pre-processed images. This novel Deep Hybrid Learning model, though derived from classical machine learning algorithms and standard CNN, showed a training and validation AUC score of 0.99 whereas the test AUC score turned out to be 1.00. The improved feature engineering enabled us to differentiate between cancerous and non-cancerous samples successfully from this pilot study.

7 November 2014 in Biochemistry
Verified
Journal Article
Closed access
MBMANINDRA Bera
MANINDRA Bera
HKHema Chandra Kotamarthi
Hema Chandra Kotamarthi
SDSubarna Dutta
Subarna Dutta
ARAngana Ray
Angana Ray
SGSaptaparni Ghosh
Saptaparni Ghosh
KSKaushik Sengupta
Kaushik Sengupta

1 November 2017 in Biochimica et Biophysica Acta (BBA) - General Subjects
Verified
Journal Article
Closed access
PBPritha Bhattacharjee
Pritha Bhattacharjee
DDDipak Dasgupta
Dipak Dasgupta
KSKaushik Sengupta
Kaushik Sengupta

14 September 2018 in Scientific Reports
Verified
Journal Article
Open access
PDF file
SDSubarna Dutta
Subarna Dutta
JDJitendra K. Das
Jitendra K. Das
LMLakshmi Maganti
Lakshmi Maganti
MBMaitree Bhattacharyya
Maitree Bhattacharyya
DBDhananjay Bhattacharyya
Dhananjay Bhattacharyya
KSKaushik Sengupta
Kaushik Sengupta
Mutations in the different domains of A-type lamin proteins cause a diverse plethora of diseases collectively termed as laminopathies which can affect multiple organs. Ig fold is one such domain of lamin A which is implicated in numerous nuclear interactions wherein the mutations lead to different laminopathies. W514R is one such mutation in the Ig fold which leads to severe phenotypes in Skeletal Muscle Dystrophy (SMD) which is a class of laminopathies. In this report, we elucidated gross alterations in structure and dynamics at the level of individual amino acids. These studies indicate altered conformational features of residues in the close vicinity of W514. Imaging of mammalian cells transfected with the mutant have shown distinct perturbation of the nuclear meshwork with concomitant alteration in nuclear interactions as a result of increased oligomerization of Ig W514R. Hence, this novel approach of amalgamating theoretical and experimental procedures to predict the severity of a mutant in the context of laminopathies could be extended for numerous lamin A mutants.